Cargando…
Impaired cardiac pump function assessment with normalized cardiac power using cardiac magnetic resonance in patients with hypertrophic cardiomyopathy
BACKGROUND: Cardiac power (CP; CP = 0.222 × cardiac output × mean blood pressure) output in patients with heart failure has been studied previously, but its importance in patients with hypertrophic cardiomyopathy (HCM) remains unclear. The present study aimed to explore the role of normalized CP (no...
Autores principales: | Li, Qing, Gao, Xuelian, Zhou, Zhen, Zhang, Hongkai, Li, Wenjie, Gao, Yifeng, Bo, Kairui, Wang, Hui, Wang, Rui, Sun, Zhonghua, Xu, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347308/ https://www.ncbi.nlm.nih.gov/pubmed/37456301 http://dx.doi.org/10.21037/qims-22-1119 |
Ejemplares similares
-
Cardiac Sarcoidosis Mimicking Hypertrophic Cardiomyopathy: The Importance of Cardiac Magnetic Resonance Imaging
por: Feldman, Daniel R., et al.
Publicado: (2020) -
Cardiac Magnetic Resonance and Computed Tomography in Hypertrophic
Cardiomyopathy: an Update
por: de Oliveira, Diogo Costa Leandro, et al.
Publicado: (2016) -
Cardiac magnetic resonance imaging in the evaluation of patients with hypertrophic cardiomyopathy
por: Brenes, Juan Carlos, et al.
Publicado: (2018) -
Post-Mortem Cardiac Magnetic Resonance for the Diagnosis of Hypertrophic Cardiomyopathy
por: Aquaro, Giovanni Donato, et al.
Publicado: (2020) -
Tumoral Phenocopies of Hypertrophic Cardiomyopathy: The Role of Cardiac Magnetic Resonance
por: Bombace, Sara, et al.
Publicado: (2021)